Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Total Liabilities: 2009-2024

Historic Total Liabilities for Fresenius Medical Care AG (FMS) over the last 17 years, with Q3 2025 value amounting to $19.8 billion.

  • Fresenius Medical Care AG's Total Liabilities rose 199.7% to $19.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $19.8 billion, marking a year-over-year increase of 199.7%. This contributed to the annual value of $19.3 billion for FY2024, which is 627.83% down from last year.
  • As of Q3 2025, Fresenius Medical Care AG's Total Liabilities stood at $19.8 billion, which was up 199.7% from $19.2 billion recorded in Q2 2025.
  • In the past 5 years, Fresenius Medical Care AG's Total Liabilities registered a high of $24.3 billion during Q2 2021, and its lowest value of $1.1 billion during Q4 2021.
  • For the 5-year period, Fresenius Medical Care AG's Total Liabilities averaged around $19.2 billion, with its median value being $20.9 billion (2024).
  • As far as peak fluctuations go, Fresenius Medical Care AG's Total Liabilities soared by 127186.5% in 2023, and later tumbled by 1312.35% in 2025.
  • Fresenius Medical Care AG's Total Liabilities (Quarter) stood at $1.1 billion in 2021, then skyrocketed by 31.97% to $1.5 billion in 2022, then skyrocketed by 1271.87% to $20.6 billion in 2023, then dropped by 7.47% to $19.0 billion in 2024, then increased by 4.36% to $19.8 billion in 2025.
  • Its Total Liabilities stands at $19.8 billion for Q3 2025, versus $19.2 billion for Q2 2025 and $18.1 billion for Q1 2025.